The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study.

The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study.
复制标题

催产素和加兰他敏对客观定义的声音和面部表情的影响:来自 CIDAR 研究的数据。

DOI:
10.1016/j.schres.2017.01.028
复制
发表时间:
2017-10
影响因子:
4.5
通讯作者:
Carpenter WT
Carpenter WT
中科院分区:
医学2区
文献类型:
--
作者:
Cohen AS;Mitchell KR;Strauss GP;Blanchard JJ;Buchanan RW;Kelly DL;Gold J;McMahon RP;Adams HA;Carpenter WT

文献摘要

参考文献

被引文献

相似文献

请将信件发送至:Alex S. Cohen, Ph. D., Louisiana State University, Department of Psychology, 236 Audubon Hall, Baton Rouge, LA 70803, USA,电话:(225) 578-7017,acohen@lsu。教育。贡献者。亚历克斯·科恩 (Alex S Cohen) 是该项目的主要作者,进行了统计分析并撰写了大部分手稿。所有其他作者都帮助管理文献检索、解释研究结果并为该项目的规划和演示提供概念材料。所有作者都对最终手稿做出了贡献并已批准。利益冲突和财务支持声明:Robert W. Buchanan:DSMB 成员:顾问:AbbVie;顾问委员会:艾伯维;安进;勃林格殷格翰-RCV;恩维沃;灵北;武田; Deanna L. Kelly:顾问委员会:Otsuka、XOMA 和 Janssen; Elaine Weiner:没有需要披露的竞争利益或财务支持; James M. Gold:顾问:Amgen 和 Hoffman LaRoche;并从 BACS 接收特许权使用费; Gregory P. Strauss:从 ProPhase LLC 收取与简短负面症状量表的商业用途和其他专业活动有关的特许权使用费和咨询费; Maju M. Koola:没有需要披露的竞争利益或财务支持; Robert P. McMahon:没有需要披露的竞争利益或财务支持; William T. Carpenter:顾问:HealthAnalytics 和 Pharmagenesis;顾问委员会:Allergen 和 Teva。
Send correspondence to: Alex S. Cohen, Ph. D., Louisiana State University, Department of Psychology, 236 Audubon Hall, Baton Rouge, LA 70803, USA, Phone:(225) 578-7017, acohen@ lsu. edu. Contributors. Alex S Cohen was the primary author for this project, conducted the statistical analyses and wrote the bulk of the manuscript. All other authors helped manage the literature searches, interpret the findings and provided conceptual material to the planning and presentation of this project. All authors contributed to and have approved the final manuscript. Conflict of Interest and Financial Support Statement: Robert W. Buchanan: DSMB member: Consultant: AbbVie; Advisory Board: AbbVie; Amgen; Boehringer Ingelheim-RCV; EnVivo; Lundbeck; Takeda; Deanna L. Kelly: Advisory Board: Otsuka, XOMA and Janssen; Elaine Weiner: no competing interests or financial support to disclose; James M. Gold: Consultant: Amgen and Hoffman LaRoche; and receives royalty payments from the BACS.; Gregory P. Strauss: receives royalties and consultation fees from ProPhase LLC in connection with the commercial use of the Brief Negative Symptom Scale and other professional activities; Maju M. Koola: no competing interests or financial support to disclose; Robert P. McMahon: no competing interests or financial support to disclose; and William T. Carpenter: Consultant: HealthAnalytics and Pharmagenesis; Advisory Board: Allergen and Teva.
DOI: 10.1016/j.schres.2013.05.003
发表时间: 2013-08-01
影响因子: 4.5
作者:
Cohen, Alex S.;Morrison, Sean C.;Callaway, Dallas A.
通讯作者: Callaway, Dallas A.
DOI: 10.1037/abn0000136
发表时间: 2016-02-01
影响因子: 4.6
作者:
Cohen, Alex S.;Mitchell, Kyle R.;Horan, William P.
通讯作者: Horan, William P.
DOI: 10.1176/appi.ajp.2007.06081358
发表时间: 2007-10-01
影响因子: 17.7
作者:
Buchanan, Robert W.;Javitt, Daniel C.;Carpenter, William T.
通讯作者: Carpenter, William T.
DOI: 10.1177/0963721411417547
发表时间: 2011-08-01
影响因子: 7.2
作者:
Kemp, Andrew H.;Guastella, Adam J.
通讯作者: Guastella, Adam J.
DOI: 10.1016/j.schres.2013.01.001
发表时间: 2013-04
影响因子: 4.5
作者:
Lee MR;Wehring HJ;McMahon RP;Linthicum J;Cascella N;Liu F;Bellack A;Buchanan RW;Strauss GP;Contoreggi C;Kelly DL
通讯作者: Kelly DL